Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2018

Conditions
Tuberous Sclerosis Complex
Trial Locations (5)

35294

University of Alabama at Birmingham, Birmingham

45229

Cincinnati Children's Hospital, Cincinnati

77030

University of Texas in Houston, Houston

90095

UCLA, Los Angeles

02115

Boston Children's Hospital, Boston

All Listed Sponsors
collaborator

Children's Hospital Medical Center, Cincinnati

OTHER

collaborator

The University of Texas Health Science Center, Houston

OTHER

collaborator

University of California, Los Angeles

OTHER

collaborator

Boston Children's Hospital

OTHER

lead

University of Alabama at Birmingham

OTHER

NCT01767779 - Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC | Biotech Hunter | Biotech Hunter